-
Mashup Score: 0Plan to attend these Late-Breaking Science sessions - 50 minute(s) ago
Learn the latest research results during these Late-Breaking Sessions.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 58#AHA24 Late-Breaking and Featured Science announced - 17 day(s) ago
See the impressive lineup of science planned for presentation at Scientific Sessions 2024.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
#AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3
-
-
Mashup Score: 57#AHA24 Late-Breaking and Featured Science announced - 1 month(s) ago
See the impressive lineup of science planned for presentation at Scientific Sessions 2024.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
#AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3
-
-
Mashup Score: 54#AHA24 Late-Breaking and Featured Science announced - 1 month(s) ago
See the impressive lineup of science planned for presentation at Scientific Sessions 2024.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
#AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3
-
-
Mashup Score: 52#AHA24 Late-Breaking and Featured Science announced - 1 month(s) ago
See the impressive lineup of science planned for presentation at Scientific Sessions 2024.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
#AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3
-
-
Mashup Score: 25Sunday's TCT programming at AHA - 1 year(s) ago
Watch for this TCT programming at #AHA23.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
Don’t miss #TCT #AHA2023 @AHAMeetings @TCTConference @crfheart sessions ➡️ https://t.co/5rxIWselPS Structural heart this morning with @jgranadacrf @JoChikweMD @tiffchenMD & many more 🌟@triciarawh @MartyBLeon https://t.co/4G2i4q38RZ
-
-
Mashup Score: 3
Join us to learn how you can make an impact
Source: sessions.hub.heart.orgCategories: General Medicine News, Cardiologists1Tweet-
This Sat #AHA23, join us at 5pm to discuss how we can address the amputation epidemic in our backyards using a NEW national #amputationmap #PAD @SVM_tweets @Cardiology https://t.co/9NX5k3XPuV https://t.co/VQrrC3R3r2
-
-
Mashup Score: 300Late-Breaking Science announced - 1 year(s) ago
See the impressive lineup of Late-Breaking Science on tap for presentation in Philadelphia.
Source: sessions.hub.heart.orgCategories: General Medicine News, CardiologistsTweet-
Trials of this year's #AHA that intrigue me the most: 1) SELECT on semaglutide 2) ORBITA-2 on PCI 3) DAPA-MI on dapagliflozin 4) AZALEA on abelacimab 5) ARTESIA on apixaban 6) REMAIN-2 on recaticimab 7) A trial of lepodisiran 8) VERVE-101 on gene editing https://t.co/cP74P3GsyW
-
-
Mashup Score: 19Late-Breaking Science announced - 1 year(s) ago
See the impressive lineup of Late-Breaking Science on tap for presentation in Philadelphia.
Source: sessions.hub.heart.orgCategories: Cardiologists, Latest HeadlinesTweet-
Trials of this year's #AHA that intrigue me the most: 1) SELECT on semaglutide 2) ORBITA-2 on PCI 3) DAPA-MI on dapagliflozin 4) AZALEA on abelacimab 5) ARTESIA on apixaban 6) REMAIN-2 on recaticimab 7) A trial of lepodisiran 8) VERVE-101 on gene editing https://t.co/cP74P3GsyW
-
To add calendar. https://t.co/e3GTUgiBjD